SpectraScience Inc (San Diego, CA) acquired the assets of Oncoscope Inc (Durham, NC). Oncoscope developed a proprietary optical imaging system to provide immediate, minimally-invasive detection of pre-cancerous epithelial tissues using scattered white light. Its first target indication was for Barrett’s Esophagus, a precursor for cancer of the esophagus. Terms of the acquisition were not disclosed.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.